Fixed-drug eruption caused by allylisopropylacetylurea.

Contact Dermatitis

Department of Dermatology, Nippon Medical School Second Hospital, Kawasaki-city, Kanagawa, Japan.

Published: March 2001

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0536.2001.440308-10.xDOI Listing

Publication Analysis

Top Keywords

fixed-drug eruption
4
eruption caused
4
caused allylisopropylacetylurea
4
fixed-drug
1
caused
1
allylisopropylacetylurea
1

Similar Publications

Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors.

J Clin Med

December 2024

Department of Cardiology-Internal Medicine and Ambulatory Care, Prevention and Cardiovascular Recovery, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Diabetes is a complex global healthcare burden involving multiple organ systems with its prevalence on the rise. SGLT2 inhibitors enhance glucose excretion. The objective of our literature review was to determine the association between cutaneous adverse drug reactions (CADRs) and the use of SGLT2 inhibitors.

View Article and Find Full Text PDF

Fixed drug eruption (FDE) is a type of drug-induced skin inflammation characterized by the recurrence of lesions in the same region following repeated exposure to the causative drug. FDE typically presents as localized spots or plaques without systemic symptoms; however, it can manifest in other forms, such as blisters and papules. In FDE, effector memory CD8-positive T cells that remain dormant in the basal layer after a previous inflammation are reactivated upon re-exposure to the causative drug, leading to the development of erythema at the same sites.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!